James J. Mulé
Impact in
- Immunology top 0.1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 0.2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 133
- Immunotherapy and Immune Responses 100
- Immune Cell Function and Interaction 49
- T-cell and B-cell Immunology 35
- Immune cells in cancer 13
- Oncology 94
- CAR-T cell therapy research 53
- Cancer Immunotherapy and Biomarkers 31
- Co-authors
- Steven A. Rosenberg (37 shared papers)S A Rosenberg (14 shared papers)Koïchi Shimizu (6 shared papers)Paul J. Spiess (5 shared papers)Shari Pilon‐Thomas (22 shared papers)Cheryl M. Reichert (3 shared papers)Ryan Courtney Fields (4 shared papers)Nicholas P. Restifo (9 shared papers)
- Journals
- The Journal of Immunology (22 papers)Journal of Immunotherapy (9 papers)Journal of Clinical Investigation (8 papers)Human Gene Therapy (7 papers)Journal for ImmunoTherapy of Cancer (7 papers)
- Partner nations
- United StatesFranceMalaysia
In The Last Decade
James J. Mulé
181 papers receiving 14.1k citations
James J. Mulé's Hit Papers
Peers
Comparison fields: 5 of 127
- Immunology 9.4k
- Oncology 6.3k
- Biotechnology 605
- Cancer Research 865
- Genetics 1.7k
Countries citing papers authored by James J. Mulé
This map shows the geographic impact of James J. Mulé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Mulé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Mulé more than expected).
Fields of papers citing papers by James J. Mulé
This network shows the impact of papers produced by James J. Mulé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Mulé. The network helps show where James J. Mulé may publish in the future.
Co-authors
The 25 scholars most cited alongside James J. Mulé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity Hit paper breakdown → | 2005 | 882 |
| 2 | Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. Hit paper breakdown → | 1985 | 643 |
| 3 | Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2 Hit paper breakdown → | 1984 | 607 |
| 4 | 2002 | 565 | |
| 5 | 1993 | 553 | |
| 6 | Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy Hit paper breakdown → | 2016 | 519 |
| 7 | 1998 | 411 | |
| 8 | 1991 | 363 | |
| 9 | 2012 | 352 | |
| 10 | 2011 | 341 | |
| 11 | Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. | 2001 | 280 |
| 12 | 1985 | 274 | |
| 13 | 1987 | 266 | |
| 14 | 1991 | 255 | |
| 15 | 2018 | 236 | |
| 16 | 1994 | 224 | |
| 17 | 1990 | 206 | |
| 18 | A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer. | 2002 | 196 |
| 19 | 1987 | 193 | |
| 20 | 1989 | 182 |
About James J. Mulé
James J. Mulé is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Biotechnology, having authored 185 papers that have together received 14.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (100 papers), CAR-T cell therapy research (53 papers), Immune Cell Function and Interaction (49 papers), T-cell and B-cell Immunology (35 papers), Cancer Immunotherapy and Biomarkers (31 papers), Virus-based gene therapy research (20 papers), RNA Interference and Gene Delivery (16 papers) and Immune cells in cancer (13 papers). The work is most often cited by research in Immunology (9.4k citations), Oncology (6.3k citations), Biotechnology (605 citations), Cancer Research (865 citations) and Genetics (1.7k citations). James J. Mulé has collaborated with scholars based in United States, France and Malaysia. Frequent co-authors include Steven A. Rosenberg, S A Rosenberg, Koïchi Shimizu, Paul J. Spiess, Shari Pilon‐Thomas, Cheryl M. Reichert, Ryan Courtney Fields, Nicholas P. Restifo, Anders Berglund and Susan L. Schwarz. Their work appears in journals such as The Journal of Immunology, Journal of Immunotherapy, Journal of Clinical Investigation, Human Gene Therapy and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.